The observation of CSGALNACT2 downregulation in ovarian cancer tissue and metastatic lesions encourages us to further investigate the impact of experimental downregulation of CSGALNACT2 on HGSOC in vitro. This evidence concerns the gene CSGALNACT2 and ovarian cancer.